# Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

> **NCT00160160** · NA · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 440 (—)

## Conditions studied

- Hypertension
- Type 2 Diabetes

## Interventions

- **DRUG:** eprosartan/HCTZ

## Key facts

- **NCT ID:** NCT00160160
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 440 (—)
- **Last updated:** 2009-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160160, "Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00160160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*